HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Toru Kita Selected Research
Toru Kita Research Topics
Disease
37
Atherosclerosis
11/2018 - 05/2002
24
Myocardial Infarction
09/2017 - 01/2003
22
Coronary Artery Disease (Coronary Atherosclerosis)
06/2022 - 01/2003
21
Heart Failure
01/2013 - 11/2003
18
Glomerulonephritis
01/2016 - 09/2003
16
Hypercholesterolemia
04/2012 - 12/2002
15
Hypertension (High Blood Pressure)
02/2021 - 01/2003
15
Stroke (Strokes)
10/2015 - 11/2005
12
Thrombosis (Thrombus)
06/2015 - 07/2003
12
Hypertrophy
03/2010 - 05/2003
11
Atherosclerotic Plaque (Atheroma)
12/2012 - 02/2004
10
Acute Coronary Syndrome
09/2017 - 12/2004
10
Hemorrhage
08/2014 - 02/2005
9
Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 02/2004
8
Coronary Disease (Coronary Heart Disease)
02/2021 - 12/2002
8
Diabetic Nephropathies (Diabetic Nephropathy)
08/2015 - 04/2004
8
Body Weight (Weight, Body)
03/2010 - 01/2003
7
Inflammation (Inflammations)
03/2017 - 04/2007
6
Type 2 Diabetes Mellitus (MODY)
10/2016 - 03/2002
6
Diabetes Mellitus
01/2015 - 01/2004
6
Obesity
03/2010 - 01/2003
6
Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2010 - 01/2003
5
Neoplasms (Cancer)
01/2021 - 03/2004
5
Alzheimer Disease (Alzheimer's Disease)
01/2014 - 06/2003
5
Insulin Resistance
03/2010 - 03/2008
4
Unstable Angina
09/2017 - 03/2007
4
Myocardial Ischemia (Ischemic Heart Diseases)
09/2017 - 01/2003
4
Cardiac Sudden Death (Sudden Cardiac Arrest)
02/2012 - 03/2007
4
Rupture
09/2010 - 02/2004
4
Hyperlipidemias (Hyperlipidemia)
01/2009 - 03/2002
4
IGA Glomerulonephritis (IGA Nephropathy)
03/2007 - 08/2004
4
Proteinuria
02/2007 - 03/2002
3
Dyslipidemias (Dyslipidemia)
02/2021 - 06/2008
3
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2021 - 01/2004
3
Chronic Kidney Failure (Chronic Renal Failure)
01/2015 - 01/2006
3
Chronic Renal Insufficiency
01/2015 - 08/2009
3
Anemia
10/2011 - 06/2006
3
Vascular Diseases (Vascular Disease)
01/2009 - 01/2004
3
Vascular System Injuries
02/2008 - 03/2004
3
Sarcoidosis (Schaumann Disease)
03/2007 - 07/2005
3
Infections
03/2007 - 08/2003
3
Reperfusion Injury
01/2007 - 01/2003
Drug/Important Bio-Agent (IBA)
29
Lipids
IBA
02/2021 - 05/2002
21
oxidized low density lipoprotein
IBA
02/2021 - 03/2002
18
Cholesterol
IBA
06/2014 - 03/2002
14
Proteins (Proteins, Gene)
FDA Link
01/2021 - 05/2003
11
Biomarkers (Surrogate Marker)
IBA
09/2017 - 11/2006
10
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 08/2006
9
Apolipoproteins E (ApoE)
IBA
12/2012 - 09/2004
9
Apolipoproteins
IBA
09/2011 - 12/2005
9
Triglycerides (Triacylglycerol)
IBA
03/2010 - 01/2003
9
Simvastatin (Zocor)
FDA Link
Generic
03/2010 - 12/2002
8
HDL Cholesterol
IBA
02/2021 - 01/2003
8
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
06/2016 - 07/2008
7
Lectins
IBA
09/2010 - 08/2005
7
Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)
IBA
09/2010 - 07/2005
6
LDL Cholesterol
IBA
02/2021 - 01/2004
6
Eicosapentaenoic Acid
IBA
01/2012 - 07/2008
5
MicroRNAs (MicroRNA)
IBA
03/2017 - 08/2009
5
omega-Chloroacetophenone (Mace)
IBA
10/2015 - 08/2009
5
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2015 - 02/2009
5
Sirolimus (Rapamycin)
FDA Link
04/2014 - 06/2005
5
Cytokines
IBA
11/2012 - 12/2002
5
Collagen
IBA
03/2010 - 05/2004
4
Probucol (Lorelco)
FDA Link
06/2022 - 12/2008
4
LDL Lipoproteins (beta Lipoproteins)
IBA
02/2021 - 01/2004
4
Fatty Acids (Saturated Fatty Acids)
IBA
01/2015 - 05/2010
4
Peptides (Polypeptides)
IBA
01/2014 - 12/2005
4
C-Reactive Protein
IBA
09/2010 - 01/2006
4
Salts
IBA
05/2010 - 11/2003
4
Transcription Factors (Transcription Factor)
IBA
03/2010 - 05/2003
4
Chemokine CXCL16
IBA
10/2009 - 02/2004
4
Brain Natriuretic Peptide (Natrecor)
FDA Link
02/2009 - 12/2004
4
LDL Receptors (LDL Receptor)
IBA
10/2008 - 01/2004
4
Lipoproteins (Lipoprotein)
IBA
06/2008 - 03/2002
4
Troponin T (Troponin T1)
IBA
05/2007 - 12/2004
4
Fibrin
IBA
03/2007 - 07/2002
4
Immunoglobulin A (IgA)
IBA
03/2007 - 09/2003
3
Antioxidants
IBA
02/2021 - 06/2007
3
nardilysin
IBA
01/2021 - 01/2014
3
Antigens
IBA
09/2017 - 12/2002
3
Metals
IBA
04/2014 - 09/2008
3
Amyloid beta-Peptides
IBA
01/2014 - 12/2005
3
thienopyridine
IBA
06/2012 - 02/2009
3
Monoclonal Antibodies
IBA
03/2011 - 01/2003
3
propagermanium (Ge 132)
IBA
03/2010 - 09/2007
3
Histone Acetyltransferases (Histone Acetyltransferase)
IBA
03/2010 - 02/2006
3
Phenylephrine (Neo-Synephrine)
FDA Link
Generic
03/2010 - 09/2004
3
Superoxide Dismutase
IBA
05/2009 - 09/2004
3
Immunoglobulin G (IgG)
IBA
10/2008 - 01/2003
3
Cell Surface Receptors
IBA
10/2008 - 07/2007
3
DNA (Deoxyribonucleic Acid)
IBA
04/2008 - 02/2006
3
Transforming Growth Factor beta (TGF-beta)
IBA
06/2007 - 02/2006
3
Scavenger Receptors (Scavenger Receptor)
IBA
04/2007 - 07/2002
Therapy/Procedure
27
Therapeutics
02/2021 - 12/2002
18
Percutaneous Coronary Intervention
06/2015 - 06/2005
16
Stents
01/2015 - 12/2004
10
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2013 - 03/2007
6
Secondary Prevention
02/2021 - 12/2002
3
Operative Surgical Procedures
08/2014 - 04/2012